YAP1 and cancer: To study Hippo signaling dysregulation in human cancers, we analyzed the somatic alterations of Hippo pathway components, effectors YAP/TAZ, and transcription factors TEAD1-4 (hereafter referred to as Hippo signaling) in The Cancer Genome Atlas (TCGA).